- Home
- PROK vs SOPH Comparison
PROK vs SOPH Comparison
Compare PROK & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- SOPH
- Stock Information
- Founded
- PROK 2015
- SOPH 2011
- Country
- PROK United States
- SOPH Switzerland
- Employees
- PROK N/A
- SOPH N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PROK Health Care
- SOPH Health Care
- Exchange
- PROK Nasdaq
- SOPH Nasdaq
- Market Cap
- PROK 220.6M
- SOPH 247.0M
- IPO Year
- PROK N/A
- SOPH 2021
- Fundamental
- Price
- PROK $1.70
- SOPH $3.53
- Analyst Decision
- PROK Buy
- SOPH Strong Buy
- Analyst Count
- PROK 5
- SOPH 3
- Target Price
- PROK $4.50
- SOPH $7.00
- AVG Volume (30 Days)
- PROK 437.3K
- SOPH 29.6K
- Earning Date
- PROK 11-12-2024
- SOPH 11-05-2024
- Dividend Yield
- PROK N/A
- SOPH N/A
- EPS Growth
- PROK N/A
- SOPH N/A
- EPS
- PROK N/A
- SOPH N/A
- Revenue
- PROK N/A
- SOPH $64,488,000.00
- Revenue This Year
- PROK N/A
- SOPH $7.34
- Revenue Next Year
- PROK N/A
- SOPH $20.25
- P/E Ratio
- PROK N/A
- SOPH N/A
- Revenue Growth
- PROK N/A
- SOPH 9.85
- 52 Week Low
- PROK $1.12
- SOPH $2.70
- 52 Week High
- PROK $4.44
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- PROK 43.50
- SOPH 48.03
- Support Level
- PROK $1.95
- SOPH $3.40
- Resistance Level
- PROK $2.27
- SOPH $3.99
- Average True Range (ATR)
- PROK 0.18
- SOPH 0.30
- MACD
- PROK 0.03
- SOPH 0.02
- Stochastic Oscillator
- PROK 26.45
- SOPH 37.84
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.